医学
肺动脉高压
抗凝剂
血栓
发病机制
血栓形成
心脏病学
病态的
慢性血栓栓塞性肺高压
内科学
重症监护医学
凝结
作者
Linfang Wen,Xiaoyun Li
出处
期刊:Chinese Journal of Asthma
日期:2016-12-20
卷期号:36 (24): 1914-1917
标识
DOI:10.3760/cma.j.issn.1673-436x.2016.24.019
摘要
Pulmonary hypertension is a group of clinical syndrome characterized by increased pulmonary vascular resistance, its pathogenesis is complex and prognosis is poor.Studies have shown that situ thrombosis and blood coagulation dysfunction play an important role in the pathogenesis of pulmonary hypertension, both of them are weighted mechanisms of occurrence and development of pulmonary hypertension.However, the application of anticoagulant drugs in pulmonary hypertension has not been unified conclusion yet.In this article, we are going to expound pathological and physiological basis in application of anticoagulant drugs in pulmonary hypertension treatment, then we will review anticoagulant drugs currently in pulmonary hypertension application and the latest progress.
Key words:
Hypertension, pulmonary; Thrombus; Anticoagulation
科研通智能强力驱动
Strongly Powered by AbleSci AI